ICAD

ICAD EBIT per Share

Delisted

The EBIT per Share of ICAD (ICAD) as of Oct 28, 2026 is -0.24 USD. In the previous year, EBIT per Share was -0.29 USD — a change of -18.58% (higher).

EBIT per Share

-0.24USD

YoY

-18.58%

Last updated:

EBIT per Share of ICAD is 2024 -0.24 USD. EBIT per Share of ICAD was 2023 -0.29 USD. It decreases by -18.58% higher compared to the previous year.

The ICAD EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-0.41 USD
Jan 1, 2021
-0.44 USD
Jan 1, 2022
-0.55 USD
Jan 1, 2023
-0.29 USD
Jan 1, 2024
-0.24 USD
Jan 1, 2025 (e)
-0.30 USD
Jan 1, 2026 (e)
-0.33 USD
Jan 1, 2027 (e)
-0.41 USD
The ICAD EBIT per Share history
YEAREBIT per ShareYoY
est-0.41USD+23.01%
est-0.33USD+11.75%
est-0.30USD+24.19%
-0.24USD-18.58%
-0.29USD-47.03%
-0.55USD+24.79%
-0.44USD+8.60%
-0.41USD+22.89%
-0.33USD-31.69%
-0.48USD-43.48%
-0.86USD+39.46%
-0.61USD-67.84%
-1.91USD-3,745.64%
0.05USD-132.08%
-0.16USD-67.35%
-0.50USD-85.49%
-3.45USD+471.00%
-0.60USD+160.40%
-0.23USD-144.18%
0.53USD-472.92%
-0.14USD-83.60%
-0.86USD+33.22%
-0.64USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ICAD Stock analysis

What does ICAD do? ICAD Inc is a leading company in medical imaging and automated image processing. It was founded in 1984 and is headquartered in Nashua, New Hampshire, USA. ICAD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICAD stock

EBIT per Share of ICAD is -0.24 USD in 2024.

EBIT per Share of ICAD changed from -0.29 USD to -0.24 USD, representing a -18.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share ICAD since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ICAD

All Key Metrics — ICAD